Table 1.
Histopathology of prostatic epithelial cells in wild-type and Ercc1−/− tissue recombinants. The table depicts the most severe histopathological phenotype for each Ercc1−/− and wild-type tissue recombinant at 8, 16 and 24 weeks post-renal grafting. Only Ercc1−/− tissue recombinants displayed adenocarcinoma.
Ercc1 | (n) | Normal | Hyperplasia | PIN | Atypical glands with features of adenocarcinoma | |
---|---|---|---|---|---|---|
8 week | +/+ | 11 | 2 (18%) | 5 (46%) | 4 (35%) | 0 (0%) |
−/− | 18 | 1 (5%) | 3 (17%) | 13 (72%) | 1 (6%)* | |
16 week | +/+ | 15 | 1 (6%) | 4 (27%) | 10 (67%) | 0 (0%) |
−/− | 16 | 0 (0%) | 0 (0%) | 14 (87.5%) | 2 (12.5%)# | |
24 week | +/+ | 13 | 4 (31%) | 3 (23%) | 6 (46%) | 0 (0%) |
−/− | 17 | 0 (0%) | 0 (0%) | 14 (82%) | 3 (18%)+ |
Statistical significance between Ercc1−/− and wild-type tissue recombinants were *p = 0.020, #p = 0.0065, and +p = 0.0003 at the 8,16, and 24 week time points respectively. With serial grafting ERCC1−/− tissue recombinants progressed to a more severe histopathological phenotype more rapidly than wild-type (p=0.011).